Generics litigation arrives at top court

Posted: March 26, 2013 at 2:21 a.m.

Federal regulators pressed the Supreme Court on Monday to stop big pharmaceutical corporations from paying generic drug competitors to delay the release of their cheaper versions of brandname drugs.

This story is only available from our archives.

Business, Pages 19 on 03/26/2013


« Previous Story

Price fix claimed by state litigants

Two Arkansans have joined Blue Cross and Blue Shield policyholders around the country in litigation that seeks class status in a lawsuit that accuses the 39 insurers under ... Read »

Next Story »


Arvest completes its buy of 29 banks Arvest Bank on Monday said it completed the acquisition of 29 Bank of America locations in four states. Read »